CELLEBRITE DI LTD (CLBT) Fundamental Analysis & Valuation

NASDAQ:CLBT • IL0011794802

14.16 USD
+0.42 (+3.02%)
At close: Mar 4, 2026
14 USD
-0.16 (-1.13%)
After Hours: 3/4/2026, 8:16:08 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CLBT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall CLBT gets a fundamental rating of 6 out of 10. We evaluated CLBT against 276 industry peers in the Software industry. CLBT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CLBT is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make CLBT a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

7

1. CLBT Profitability Analysis

1.1 Basic Checks

  • In the past year CLBT was profitable.
  • In the past year CLBT had a positive cash flow from operations.
  • In multiple years CLBT reported negative net income over the last 5 years.
  • Each year in the past 5 years CLBT had a positive operating cash flow.
CLBT Yearly Net Income VS EBIT VS OCF VS FCFCLBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M

1.2 Ratios

  • CLBT has a better Return On Assets (8.34%) than 82.25% of its industry peers.
  • The Return On Equity of CLBT (16.17%) is better than 83.70% of its industry peers.
  • CLBT has a Return On Invested Capital of 10.09%. This is amongst the best in the industry. CLBT outperforms 85.87% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CLBT is in line with the industry average of 10.80%.
Industry RankSector Rank
ROA 8.34%
ROE 16.17%
ROIC 10.09%
ROA(3y)-15.95%
ROA(5y)0.33%
ROE(3y)-101.7%
ROE(5y)N/A
ROIC(3y)10.94%
ROIC(5y)9.54%
CLBT Yearly ROA, ROE, ROICCLBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

  • CLBT has a better Profit Margin (16.47%) than 82.61% of its industry peers.
  • CLBT's Profit Margin has declined in the last couple of years.
  • CLBT has a Operating Margin of 13.98%. This is amongst the best in the industry. CLBT outperforms 81.16% of its industry peers.
  • In the last couple of years the Operating Margin of CLBT has grown nicely.
  • CLBT's Gross Margin of 84.20% is amongst the best of the industry. CLBT outperforms 89.49% of its industry peers.
  • CLBT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.98%
PM (TTM) 16.47%
GM 84.2%
OM growth 3Y235.7%
OM growth 5Y24.25%
PM growth 3Y-27.32%
PM growth 5YN/A
GM growth 3Y1.2%
GM growth 5Y0.89%
CLBT Yearly Profit, Operating, Gross MarginsCLBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. CLBT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CLBT is creating some value.
  • The number of shares outstanding for CLBT has been increased compared to 1 year ago.
  • Compared to 5 years ago, CLBT has more shares outstanding
  • CLBT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CLBT Yearly Shares OutstandingCLBT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CLBT Yearly Total Debt VS Total AssetsCLBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 5.31 indicates that CLBT is not in any danger for bankruptcy at the moment.
  • CLBT's Altman-Z score of 5.31 is fine compared to the rest of the industry. CLBT outperforms 79.71% of its industry peers.
  • There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 5.31
ROIC/WACC1.14
WACC8.85%
CLBT Yearly LT Debt VS Equity VS FCFCLBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • CLBT has a Current Ratio of 1.56. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CLBT (1.56) is comparable to the rest of the industry.
  • CLBT has a Quick Ratio of 1.54. This is a normal value and indicates that CLBT is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of CLBT (1.54) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.54
CLBT Yearly Current Assets VS Current LiabilitesCLBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. CLBT Growth Analysis

3.1 Past

  • CLBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.05%, which is quite good.
  • The Earnings Per Share has been growing by 71.00% on average over the past years. This is a very strong growth
  • The Revenue has grown by 18.56% in the past year. This is quite good.
  • CLBT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.54% yearly.
EPS 1Y (TTM)19.05%
EPS 3Y71%
EPS 5YN/A
EPS Q2Q%40%
Revenue 1Y (TTM)18.56%
Revenue growth 3Y20.67%
Revenue growth 5Y19.54%
Sales Q2Q%18.13%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.98% on average over the next years. This is quite good.
  • CLBT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.73% yearly.
EPS Next Y10.09%
EPS Next 2Y12.23%
EPS Next 3Y10.98%
EPS Next 5YN/A
Revenue Next Year19.73%
Revenue Next 2Y18.6%
Revenue Next 3Y17.73%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CLBT Yearly Revenue VS EstimatesCLBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
CLBT Yearly EPS VS EstimatesCLBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

4

4. CLBT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 28.32 indicates a quite expensive valuation of CLBT.
  • Compared to the rest of the industry, the Price/Earnings ratio of CLBT indicates a somewhat cheap valuation: CLBT is cheaper than 62.32% of the companies listed in the same industry.
  • CLBT is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.03, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 25.72 indicates a quite expensive valuation of CLBT.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CLBT is on the same level as its industry peers.
  • CLBT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 25.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.32
Fwd PE 25.72
CLBT Price Earnings VS Forward Price EarningsCLBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CLBT indicates a somewhat cheap valuation: CLBT is cheaper than 64.86% of the companies listed in the same industry.
  • 73.55% of the companies in the same industry are more expensive than CLBT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.59
EV/EBITDA 33.32
CLBT Per share dataCLBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • CLBT has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.81
PEG (5Y)N/A
EPS Next 2Y12.23%
EPS Next 3Y10.98%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CLBT Dividend Analysis

5.1 Amount

  • No dividends for CLBT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CLBT Fundamentals: All Metrics, Ratios and Statistics

CELLEBRITE DI LTD

NASDAQ:CLBT (3/4/2026, 8:16:08 PM)

After market: 14 -0.16 (-1.13%)

14.16

+0.42 (+3.02%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-11
Earnings (Next)05-12
Inst Owners48.65%
Inst Owner Change-3.9%
Ins Owners0.63%
Ins Owner ChangeN/A
Market Cap3.46B
Revenue(TTM)475.68M
Net Income(TTM)78.33M
Analysts83.08
Price Target22.44 (58.47%)
Short Float %4.11%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.42%
Min EPS beat(2)1.3%
Max EPS beat(2)9.55%
EPS beat(4)4
Avg EPS beat(4)9.89%
Min EPS beat(4)1.3%
Max EPS beat(4)15.93%
EPS beat(8)8
Avg EPS beat(8)28.1%
EPS beat(12)12
Avg EPS beat(12)50.82%
EPS beat(16)13
Avg EPS beat(16)30.81%
Revenue beat(2)1
Avg Revenue beat(2)0.53%
Min Revenue beat(2)-0.21%
Max Revenue beat(2)1.27%
Revenue beat(4)1
Avg Revenue beat(4)-0.89%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)1.27%
Revenue beat(8)4
Avg Revenue beat(8)0.17%
Revenue beat(12)8
Avg Revenue beat(12)1.06%
Revenue beat(16)8
Avg Revenue beat(16)-0.34%
PT rev (1m)-10.98%
PT rev (3m)-10.98%
EPS NQ rev (1m)-8.5%
EPS NQ rev (3m)-10.14%
EPS NY rev (1m)0%
EPS NY rev (3m)3.16%
Revenue NQ rev (1m)-2.9%
Revenue NQ rev (3m)-3.31%
Revenue NY rev (1m)2.08%
Revenue NY rev (3m)3.24%
Valuation
Industry RankSector Rank
PE 28.32
Fwd PE 25.72
P/S 7.28
P/FCF 21.59
P/OCF 19.95
P/B 7.15
P/tB 12.22
EV/EBITDA 33.32
EPS(TTM)0.5
EY3.53%
EPS(NY)0.55
Fwd EY3.89%
FCF(TTM)0.66
FCFY4.63%
OCF(TTM)0.71
OCFY5.01%
SpS1.95
BVpS1.98
TBVpS1.16
PEG (NY)2.81
PEG (5Y)N/A
Graham Number4.72
Profitability
Industry RankSector Rank
ROA 8.34%
ROE 16.17%
ROCE 11.68%
ROIC 10.09%
ROICexc 43.46%
ROICexgc N/A
OM 13.98%
PM (TTM) 16.47%
GM 84.2%
FCFM 33.7%
ROA(3y)-15.95%
ROA(5y)0.33%
ROE(3y)-101.7%
ROE(5y)N/A
ROIC(3y)10.94%
ROIC(5y)9.54%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.66%
ROCE(5y)11.04%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y205.37%
ROICexc growth 5YN/A
OM growth 3Y235.7%
OM growth 5Y24.25%
PM growth 3Y-27.32%
PM growth 5YN/A
GM growth 3Y1.2%
GM growth 5Y0.89%
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 111.44%
Cap/Sales 2.78%
Interest Coverage 250
Cash Conversion 221.51%
Profit Quality 204.68%
Current Ratio 1.56
Quick Ratio 1.54
Altman-Z 5.31
F-Score5
WACC8.85%
ROIC/WACC1.14
Cap/Depr(3y)96.85%
Cap/Depr(5y)101.03%
Cap/Sales(3y)2.62%
Cap/Sales(5y)2.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.05%
EPS 3Y71%
EPS 5YN/A
EPS Q2Q%40%
EPS Next Y10.09%
EPS Next 2Y12.23%
EPS Next 3Y10.98%
EPS Next 5YN/A
Revenue 1Y (TTM)18.56%
Revenue growth 3Y20.67%
Revenue growth 5Y19.54%
Sales Q2Q%18.13%
Revenue Next Year19.73%
Revenue Next 2Y18.6%
Revenue Next 3Y17.73%
Revenue Next 5YN/A
EBIT growth 1Y16.82%
EBIT growth 3Y305.1%
EBIT growth 5Y48.52%
EBIT Next Year28.35%
EBIT Next 3Y23.3%
EBIT Next 5YN/A
FCF growth 1Y31.88%
FCF growth 3Y140.74%
FCF growth 5Y21.59%
OCF growth 1Y31.3%
OCF growth 3Y103.54%
OCF growth 5Y21.14%

CELLEBRITE DI LTD / CLBT FAQ

What is the fundamental rating for CLBT stock?

ChartMill assigns a fundamental rating of 6 / 10 to CLBT.


What is the valuation status of CELLEBRITE DI LTD (CLBT) stock?

ChartMill assigns a valuation rating of 4 / 10 to CELLEBRITE DI LTD (CLBT). This can be considered as Fairly Valued.


What is the profitability of CLBT stock?

CELLEBRITE DI LTD (CLBT) has a profitability rating of 7 / 10.


How financially healthy is CELLEBRITE DI LTD?

The financial health rating of CELLEBRITE DI LTD (CLBT) is 7 / 10.


What is the expected EPS growth for CELLEBRITE DI LTD (CLBT) stock?

The Earnings per Share (EPS) of CELLEBRITE DI LTD (CLBT) is expected to grow by 10.09% in the next year.